US patent for ‘CARTISTEM’ raw material stem cell differentiation capability selection technology2014/05/15STEM CELL THERAPEUTIC
Successful administration of stem cell dementia treatment drug ‘NEUROSTEM’2014/04/28STEM CELL THERAPEUTIC
Clinical thesis for lung treatment ‘PNEUMOSTEM’ published in international academic journal2014/02/10STEM CELL THERAPEUTIC
Football Manager Guus Hiddink, receives arthritis surgery with MEDIPOST’s stem cell technology2014/01/09STEM CELL THERAPEUTIC
Designated ‘Stem Cell Hair Growth Solution’ research institution by Ministry Commerce, Industry and Energy2013/12/20STEM CELL THERAPEUTIC
Strengthening marketing of ‘CARTISTEM’ by participating in numerous overseas academic conferences2013/12/09STEM CELL THERAPEUTIC
MEDIPOST Enhances its Partnership with Canada’s OmniaBio in Collaboration for the CMDO Business of OmniaBio’s All-Around Cell and Gene Therapy.2022/12/01
Medipost to launch a CDMO business for cell and gene therapy products in Korea based on 20 years of research and production knowledge2022/10/17
Medipost enters North American market by acquiring OmniaBio, a CDMO company with cell and gene therapy products2022/05/31
